Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1929 of 6351
-
Exercise and diet combo shows promise for diabetes control
Disease control CompletedThe aim of this randomized controlled trial is to investigate the effects of different aerobic modalities; moderate-intensity continuous training (MICT) and high-intensity interval training (HIIT), and a nutritional intervention (D) on appetite regulation, appetite-related hormon…
Sponsor: University of Cadiz • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Magic mushroom therapy tested for End-of-Life distress
Symptom relief CompletedThe overall objective of this study is to develop and pilot test a novel regimen of psilocybin-assisted psychotherapy for demoralization in patients receiving hospice care. -The name of the study drug involved in this study is Psilocybin
Phase 2 • Sponsor: Yvan Beaussant, MD, MSci • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New hope for rare autoimmune disease: baricitinib trial underway
Disease control OngoingSystemic Sclerosis (Ssc) is a rare, systemic autoimmune disease characterized by skin fibrosis and vasculopathy. In addition to the skin, it is a heterogeneous disease that affects multiple organs, including the musculoskeletal, cardiac, pulmonary, and gastrointestinal systems. P…
Phase 4 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
CBD shows promise in cutting opioid use and pain
Symptom relief CompletedThis is a double-blind, placebo-controlled, parallel group study designed to assess the tolerability and efficacy of fsCBD and bsCBD, compared to a placebo control, to reduce opioid use, anxiety, and pain and improve sleep and cognitive function. If eligible for the study, subjec…
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Experimental gene therapy targets common cancer protein
Disease control Stopped earlyBackground: Researchers have found a new way to treat cancer using T cell therapy. The therapy used in this study is T Cell Receptor (TCR) Gene Therapy Targeting Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1), a cancer germline antigen that is expressed by certain cancers. This the…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can exercise and diet beat muscle loss in seniors? new study says maybe.
Disease control CompletedThis study aims to demonstrate the effect of combined exercise-nutrition intervention in old adults with sarcopenia. This study will be conducted with prospectively randomized controlled trial comparing outcome of combined exercise-nutrition intervention with conventional medical…
Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:55 UTC
-
Robot-Assisted breast surgery trial aims for better outcomes and sensation
Disease control Recruiting nowThis is a single arm, single-center, prospective clinical trial designed to track the peri, post-operative and oncologic outcomes when utilizing the da-Vinci single port (SP) robotic platform to perform robotic nipple sparing mastectomy (rNSM) and immediate breast reconstruction …
Sponsor: Deborah Farr, MD • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New pill could curb binge eating episodes
Disease control CompletedThis pilot study is to assess the efficacy and safety of BP1.4979 15 mg BID in female patients with moderate to severe binge eating disorder (BED), as defined according to DSM-5 guidelines.
Phase 2 • Sponsor: Bioprojet • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug combo KarXT tested for Long-Term safety in schizophrenia
Disease control CompletedThis is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive KarXT in subjects with schizophrenia with an inadequate response to their current antipsychotic treatment who previously completed…
Phase 3 • Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Experimental drug targets rare pancreatic cancer in small trial
Disease control CompletedBackground: Pancreatic cancer is one of the most lethal types of cancer. American Society for Clinical Pathology (ASCP) is a highly aggressive type of pancreatic cancer. It is very rare. Researchers want to see if a drug called Minnelide can be used to treat ASCP. Objective: T…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for Hard-to-Treat leukemia: Two-Drug combo enters human trials
Disease control Recruiting nowThis study will assess the safety, tolerability, pharmaokinetics, and preliminary efficacy of mosunetuzumab (Lunsumio) monotherapy in participants with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This study will also allow …
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New shot aims to tame genital herpes outbreaks
Disease control CompletedThe purpose of this first-time-in-human (FTiH) study is to evaluate the reactogenicity, safety, immune response, and efficacy of an investigational herpes simplex virus (HSV)-targeted immunotherapy (TI). The study will be conducted in 2 parts: Part I assessing different formulati…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 26, 2026 14:33 UTC
-
New shot may curb heavy drinking in reward-driven people
Disease control Recruiting nowThis study is a phase IV, two-arm, randomized, double-blind, placebo-controlled study to assess whether individuals identified as primarily reward drinkers are significantly more likely to reduce heavy drinking if they receive XR-NTX than a matching placebo injection. Study subj…
Phase 4 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a common arthritis drug hold off a rare blood cancer?
Disease control OngoingThis phase II trial studies the effects of leflunomide in treating African-American and European-American patients with high-risk smoldering multiple myeloma. Leflunomide is used to decrease the body's immune response and may delay the symptoms of multiple myeloma in patients of …
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Do Heart-Strengthening drugs actually help in shock? major trial aims to find out
Disease control Recruiting nowThe investigators are interested in determining if there is a meaningful benefit from the use of medications purported to increase the pumping function of the heart (i.e. inotropes) among critically ill patients admitted to the Cardiac Intensive Care Unit (CICU). To do this, the …
Phase 4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Heart shield for chemo: new trial aims to protect AML patients
Disease control Recruiting nowPatients with acute myeloid leukemia (AML) often receive a drug called daunorubicin. Daunorubicin is a type of drug called an anthracycline, which increases the risk of some damage to the heart. Beta blockers and angiotensin-converting enzyme inhibitors (ACEi) are two types of dr…
Phase 2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Seizure drug safety trial halted early for dravet and LGS patients
Disease control Stopped earlyThe main aim of the study is to learn if soticlestat, when given as an add-on therapy, reduces the number of seizures in children and adults with Dravet Syndrome (DS) or Lennox-Gastaut Syndrome (LGS). Participants will receive their standard anti-seizure therapy, plus tablets of…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Miracle fruit tested as taste saver for head and neck cancer patients
Symptom relief OngoingPatients diagnosed with head and neck cancer who receive radiation therapy with and without chemotherapy develop altered sense of taste due to treatment effect, which typically arises in the second week of radiation therapy and progresses throughout the course of treatment. While…
Phase 3 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can a migraine pill taken daily or every other day stop attacks before they start?
Disease control CompletedThe purpose of this study is to compare the efficacy and safety of daily and every other day dosing of rimegepant to placebo as a preventive treatment for episodic migraine.
Phase 4 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a common diabetes drug help fight TB in HIV patients?
Disease control CompletedThe METHOD study will examine whether adding metformin to standard antibiotic treatment for tuberculosis (TB) in people with HIV is safe and well tolerated. The study will also test if adding metformin clears the infection more quickly and with less lung damage. When enrolled, pa…
Phase 2 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC